glp 1 takes insurance GLP-1 change impacts millions of Americans: What to know, how to tell if you're covered Global Health Brief: The rise

This study suggests a molecular crosstalk between the E2F1/pRb and GLP1R signaling pathways that modulates insulin secretion and glucose homeostasis

Could Retatrutide be the next breakthrough in medical weight loss

When compounded semaglutide and tirzepatide fail sterility and potency testing, and get distributed anyway, the implications extend far beyond one pharmacy.

Semaglutide patent expiry in mid-March 2026 set to trigger entry of 50+ branded generics in India: Sheetal Sapale

It is possible to be allergic to GLP-1 receptor agonist

A bariatric surgeon compares Saxenda, Wegovy, Ozempic and Zepbound, explaining how doctors decide which GLP-1 weight loss medication is best for each patient.